While it appears that IRF8 protects against the formation of Pre-B ALL, drastically increased IRF8 (such as in the case of IGH-IRF8 fusion) may promote the formation of DLBCL. This evidence concerns the gene IRF8 and diffuse large B-cell lymphoma.